Watch for Injectable Weight Loss Meds on Home Med Lists
January 2024
More home med lists will include once-weekly injectable obesity meds, semaglutide (Wegovy) or new tirzepatide (Zepbound).
Tirzepatide is the same ingredient in Mounjaro for type 2 diabetes. It’s a dual agonist...at glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
Semaglutide is the same GLP-1 agonist in injectable Ozempic or oral Rybelsus for type 2 diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote